| NCT03365479 |
Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT03365479 |
Completed |
University of Giessen |
2018-08-01 |
| NCT03385733 |
Inspiratory Muscle Training in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03385733 |
Completed |
Istanbul University |
2018-02-15 |
| NCT04193046 |
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) |
https://ClinicalTrials.gov/show/NCT04193046 |
Recruiting |
Janssen Research & Development, LLC |
2021-03-31 |
| NCT04175600 |
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT04175600 |
Recruiting |
Janssen Research & Development, LLC |
2024-12-09 |
| NCT03980717 |
Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH |
https://ClinicalTrials.gov/show/NCT03980717 |
Recruiting |
Baylor College of Medicine |
2028-12-31 |
| NCT03629340 |
Metformin for Pulmonary Hypertension HFpEF |
https://ClinicalTrials.gov/show/NCT03629340 |
Recruiting |
University of Pittsburgh |
2023-06-30 |
| NCT03402191 |
L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03402191 |
Recruiting |
Tanta University |
2023-12-31 |
| NCT03399604 |
Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil |
https://ClinicalTrials.gov/show/NCT03399604 |
Active, not recruiting |
Liquidia Technologies, Inc. |
2019-05-06 |
| NCT03470207 |
The Prospective Risk Factor Evaluation & Discovery In CTEPH Study |
https://ClinicalTrials.gov/show/NCT03470207 |
Recruiting |
Intermountain Health Care, Inc. |
2021-05-31 |
| NCT03345212 |
A Randomized Controlled Multicenter Trial of Exercise Training in Pulmonary Hypertension in European Countries |
https://ClinicalTrials.gov/show/NCT03345212 |
Completed |
Heidelberg University |
2018-12-31 |
| NCT03273387 |
The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT03273387 |
Completed |
Indonesia University |
2018-11-01 |
| NCT03273257 |
Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study) |
https://ClinicalTrials.gov/show/NCT03273257 |
Recruiting |
International CTEPH Association |
2020-07-31 |
| NCT03270332 |
Effect of Inhaled Albuterol in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03270332 |
Recruiting |
University of Miami |
2021-03-31 |
| NCT03267108 |
A Safety and Efficacy Study of Pulsed Inhaled Nitric Oxide in Pulmonary Hypertension Associated With Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03267108 |
Active, not recruiting |
Bellerophon |
2022-06-16 |
| NCT03205085 |
Determinants of Right Heart Remodeling in Patients With CTEPH or PAH |
https://ClinicalTrials.gov/show/NCT03205085 |
Recruiting |
Centre Chirurgical Marie Lannelongue |
2020-07-01 |
| NCT03197792 |
Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy |
https://ClinicalTrials.gov/show/NCT03197792 |
Recruiting |
Centre Chirurgical Marie Lannelongue |
2018-05-24 |
| NCT03194438 |
Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03194438 |
Completed |
Ohio State University |
2018-06-05 |
| NCT03186092 |
Effects of Training in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03186092 |
Recruiting |
Faculdade de Ciências Médicas da Santa Casa de São Paulo |
2018-03-01 |
| NCT03185364 |
The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD |
https://ClinicalTrials.gov/show/NCT03185364 |
Recruiting |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2020-12-31 |
| NCT03177603 |
A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT03177603 |
Completed |
GlaxoSmithKline |
2019-05-07 |
| NCT03122730 |
VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB |
https://ClinicalTrials.gov/show/NCT03122730 |
Completed |
Aerogen Pharma Limited |
2019-03-01 |
| NCT03092622 |
Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia |
https://ClinicalTrials.gov/show/NCT03092622 |
Completed |
Norwegian University of Science and Technology |
2019-12-31 |
| NCT03077139 |
Cardiac Resynchronization Therapy in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03077139 |
Completed |
Ochsner Health System |
2017-03-23 |
| NCT03074539 |
Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03074539 |
Recruiting |
Medical University of Vienna |
2020-02-01 |
| NCT03068130 |
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER |
https://ClinicalTrials.gov/show/NCT03068130 |
Active, not recruiting |
Reata Pharmaceuticals, Inc. |
2021-12-31 |
| NCT03044314 |
Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03044314 |
Recruiting |
Duke University |
2020-12-01 |
| NCT03022851 |
The Prophet Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03022851 |
Recruiting |
Occlutech International AB |
2020-08-31 |
| NCT03015402 |
Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction |
https://ClinicalTrials.gov/show/NCT03015402 |
Active, not recruiting |
University of Pittsburgh |
2021-03-31 |
| NCT03001414 |
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs |
https://ClinicalTrials.gov/show/NCT03001414 |
Recruiting |
Northern Therapeutics |
2020-10-31 |
| NCT02963597 |
Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea. |
https://ClinicalTrials.gov/show/NCT02963597 |
Completed |
Albert Einstein Healthcare Network |
2017-08-31 |
| NCT02951130 |
Milrinone in Congenital Diaphragmatic Hernia |
https://ClinicalTrials.gov/show/NCT02951130 |
Recruiting |
NICHD Neonatal Research Network |
2021-02-28 |
| NCT02951104 |
Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02951104 |
Active, not recruiting |
Santa Barbara Cottage Hospital |
2020-06-30 |
| NCT02892981 |
Dead Space Evaluation in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02892981 |
Completed |
Centro Cardiologico Monzino |
2016-01-31 |
| NCT02886793 |
Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02886793 |
Completed |
Hospital Clinic of Barcelona |
2018-07-31 |
| NCT02885116 |
Effect of Nasal Highflow on Right Heart Function |
https://ClinicalTrials.gov/show/NCT02885116 |
Completed |
University of Leipzig |
2018-02-28 |
| NCT02859194 |
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients |
https://ClinicalTrials.gov/show/NCT02859194 |
Completed |
Yonsei University |
2016-10-14 |
| NCT02844036 |
Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTP |
https://ClinicalTrials.gov/show/NCT02844036 |
Completed |
University Hospital, Grenoble |
2017-10-31 |
| NCT02835950 |
TReatment Of Pulmonary HYpertension 1-US Study |
https://ClinicalTrials.gov/show/NCT02835950 |
Active, not recruiting |
SoniVie Ltd. |
2019-04-20 |
| NCT02829034 |
Targeting Right Ventricle in Pulmonary Hypertension Gilead |
https://ClinicalTrials.gov/show/NCT02829034 |
Completed |
University of Pennsylvania |
2017-12-31 |
| NCT02755298 |
Chronic Clinical Effect of Acetazolamide |
https://ClinicalTrials.gov/show/NCT02755298 |
Recruiting |
University of Zurich |
2020-06-30 |
| NCT02755259 |
Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02755259 |
Completed |
University of Zurich |
2019-04-05 |
| NCT02742909 |
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease |
https://ClinicalTrials.gov/show/NCT02742909 |
Completed |
Shengjing Hospital |
2018-12-31 |
| NCT02712294 |
Impact of NMES on Spirometry Values, Functional Capacity and Quality of Life in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02712294 |
Completed |
Faculdade de Ciências Médicas da Santa Casa de São Paulo |
2016-06-30 |
| NCT02688387 |
A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02688387 |
Completed |
GlaxoSmithKline |
2017-08-04 |
| NCT02661802 |
Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger Syndrome |
https://ClinicalTrials.gov/show/NCT02661802 |
Completed |
Federal University of São Paulo |
2014-06-30 |
| NCT02651272 |
Macitentan in Pulmonary Hypertension of Sickle Cell Disease |
https://ClinicalTrials.gov/show/NCT02651272 |
Completed |
Boston University |
2019-12-18 |
| NCT02633293 |
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE |
https://ClinicalTrials.gov/show/NCT02633293 |
Active, not recruiting |
United Therapeutics |
2022-11-30 |
| NCT02630316 |
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE |
https://ClinicalTrials.gov/show/NCT02630316 |
Completed |
United Therapeutics |
2019-12-26 |
| NCT02595541 |
Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02595541 |
Completed |
Assiut University |
2015-10-31 |
| NCT02587325 |
ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT02587325 |
Recruiting |
Aadi, LLC |
2020-12-31 |
| NCT03926572 |
Acute Decompensation of Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03926572 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-06-01 |
| NCT03626688 |
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients |
https://ClinicalTrials.gov/show/NCT03626688 |
Recruiting |
United Therapeutics |
2021-12-31 |
| NCT01757782 |
Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns |
https://ClinicalTrials.gov/show/NCT01757782 |
Completed |
Sir Takhtasinhji General Hospital |
2012-08-31 |
| NCT02980068 |
A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction |
https://ClinicalTrials.gov/show/NCT02980068 |
Recruiting |
University of Pittsburgh |
2021-01-31 |
| NCT02759419 |
A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension. |
https://ClinicalTrials.gov/show/NCT02759419 |
Recruiting |
Bayer |
2023-12-28 |
| NCT02562235 |
Riociguat in Children With Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT02562235 |
Active, not recruiting |
Bayer |
2020-03-07 |
| NCT02558582 |
Effect of Exercise Training in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02558582 |
Recruiting |
University of Zurich |
2020-12-31 |
| NCT02554903 |
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation |
https://ClinicalTrials.gov/show/NCT02554903 |
Completed |
Actelion |
2020-03-13 |
| NCT02551653 |
Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients |
https://ClinicalTrials.gov/show/NCT02551653 |
Completed |
GlaxoSmithKline |
2017-03-14 |
| NCT02516722 |
TReatment Of Pulmonary HYpertension 1 Study |
https://ClinicalTrials.gov/show/NCT02516722 |
Active, not recruiting |
SoniVie Ltd. |
2018-10-31 |
| NCT02378649 |
PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02378649 |
Completed |
Sheba Medical Center |
2018-06-30 |
| NCT02305550 |
A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation |
https://ClinicalTrials.gov/show/NCT02305550 |
Completed |
Massachusetts General Hospital |
2016-01-31 |
| NCT02290613 |
Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) |
https://ClinicalTrials.gov/show/NCT02290613 |
Completed |
Heidelberg University |
2017-11-27 |
| NCT02288442 |
Whole Muscle Exercise Training (WHOLEi+12) in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02288442 |
Completed |
Universidad Europea de Madrid |
2016-06-30 |
| NCT02261883 |
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn |
https://ClinicalTrials.gov/show/NCT02261883 |
Recruiting |
United Therapeutics |
2022-12-31 |
| NCT02223481 |
Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02223481 |
Completed |
Boehringer Ingelheim |
1999-09-30 |
| NCT02220335 |
Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left Heart Failure |
https://ClinicalTrials.gov/show/NCT02220335 |
Completed |
Nanjing First Hospital, Nanjing Medical University |
2018-06-16 |
| NCT02216279 |
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02216279 |
Completed |
Montreal Heart Institute |
2015-09-30 |
| NCT02191137 |
Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION) |
https://ClinicalTrials.gov/show/NCT02191137 |
Completed |
Bayer |
2016-07-16 |
| NCT02150616 |
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep |
https://ClinicalTrials.gov/show/NCT02150616 |
Active, not recruiting |
University of Zurich |
2020-12-31 |
| NCT02143687 |
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance |
https://ClinicalTrials.gov/show/NCT02143687 |
Active, not recruiting |
University of Zurich |
2020-12-31 |
| NCT02133352 |
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction |
https://ClinicalTrials.gov/show/NCT02133352 |
Completed |
Boston University |
2013-05-31 |
| NCT02129309 |
Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures |
https://ClinicalTrials.gov/show/NCT02129309 |
Completed |
Cambridge University Hospitals NHS Foundation Trust |
2014-12-31 |
| NCT02111980 |
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators |
https://ClinicalTrials.gov/show/NCT02111980 |
Completed |
University of California, San Diego |
2015-03-31 |
| NCT02094001 |
Pilot Study to Evaluate Right Ventricular Function With Riociguat in CTEPH |
https://ClinicalTrials.gov/show/NCT02094001 |
Completed |
Ottawa Heart Institute Research Corporation |
2016-06-30 |
| NCT02026531 |
Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease |
https://ClinicalTrials.gov/show/NCT02026531 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2015-09-30 |
| NCT02070991 |
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction |
https://ClinicalTrials.gov/show/NCT02070991 |
Completed |
Actelion |
2015-11-01 |
| NCT02060721 |
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02060721 |
Active, not recruiting |
Actelion |
2020-12-31 |
| NCT01313832 |
The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01313832 |
Completed |
Seoul National University Hospital |
2011-04-30 |
| NCT01310751 |
Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgery |
https://ClinicalTrials.gov/show/NCT01310751 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2013-12-31 |
| NCT01310153 |
Effect of Supine or Prone Position After Caesarean Birth |
https://ClinicalTrials.gov/show/NCT01310153 |
Completed |
Montefiore Medical Center |
2009-02-28 |
| NCT01306292 |
Safety of SonoVue on Pulmonary Hemodynamics |
https://ClinicalTrials.gov/show/NCT01306292 |
Completed |
Bracco Diagnostics, Inc |
2011-11-30 |
| NCT01305252 |
A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil). |
https://ClinicalTrials.gov/show/NCT01305252 |
Completed |
Stanford University |
2014-09-30 |
| NCT01287026 |
Real-time MRI Right Heart Catheterization Using Passive Catheters |
https://ClinicalTrials.gov/show/NCT01287026 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-03-21 |
| NCT01274481 |
Iloprost Effects on Gas Exchange and Pulmonary Mechanics |
https://ClinicalTrials.gov/show/NCT01274481 |
Completed |
University of Oklahoma |
2012-07-31 |
| NCT02053246 |
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure |
https://ClinicalTrials.gov/show/NCT02053246 |
Active, not recruiting |
University of Florida |
2021-03-31 |
| NCT02036970 |
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT |
https://ClinicalTrials.gov/show/NCT02036970 |
Completed |
Reata Pharmaceuticals, Inc. |
2018-01-19 |
| NCT02007629 |
Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor |
https://ClinicalTrials.gov/show/NCT02007629 |
Completed |
Bayer |
2016-12-29 |
| NCT01959828 |
Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery |
https://ClinicalTrials.gov/show/NCT01959828 |
Completed |
Mallinckrodt |
2014-03-31 |
| NCT01948518 |
Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease |
https://ClinicalTrials.gov/show/NCT01948518 |
Completed |
The Cleveland Clinic |
2012-06-30 |
| NCT01932606 |
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction |
https://ClinicalTrials.gov/show/NCT01932606 |
Completed |
Mayo Clinic |
2014-10-31 |
| NCT01917136 |
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01917136 |
Completed |
University of Pennsylvania |
2018-10-31 |
| NCT01895998 |
Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease |
https://ClinicalTrials.gov/show/NCT01895998 |
Completed |
Duke University |
2014-04-30 |
| NCT01889966 |
VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01889966 |
Completed |
Kerckhoff Heart Center |
2015-01-31 |
| NCT01884012 |
Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01884012 |
Completed |
University of Zurich |
2017-03-31 |
| NCT01862536 |
Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease |
https://ClinicalTrials.gov/show/NCT01862536 |
Active, not recruiting |
VA Office of Research and Development |
2019-08-31 |
| NCT01839110 |
Targeting the Right Ventricle in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01839110 |
Completed |
University of Pennsylvania |
2018-01-31 |
| NCT01824290 |
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT01824290 |
Active, not recruiting |
Eli Lilly and Company |
2019-03-18 |
| NCT01800292 |
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH. |
https://ClinicalTrials.gov/show/NCT01800292 |
Completed |
University of Arizona |
2013-12-31 |
| NCT01758744 |
Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1 |
https://ClinicalTrials.gov/show/NCT01758744 |
Completed |
University of Colorado, Denver |
2016-07-31 |
| NCT01748474 |
Effect of Short-term Oxygen During CPET in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01748474 |
Completed |
University of Zurich |
2016-03-31 |
| NCT01728220 |
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD |
https://ClinicalTrials.gov/show/NCT01728220 |
Completed |
Bellerophon |
2014-06-30 |
| NCT01726049 |
Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH |
https://ClinicalTrials.gov/show/NCT01726049 |
Completed |
University Medical Center Groningen |
2014-09-30 |
| NCT01725776 |
Inhaled Milrinone in Cardiac Surgery |
https://ClinicalTrials.gov/show/NCT01725776 |
Completed |
Montreal Heart Institute |
2012-02-29 |
| NCT01725763 |
Non-contrast Enhanced Cardiac Magnetic Resonance Imaging in the Diagnosis and Classification of Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01725763 |
Enrolling by invitation |
Medical University of Graz |
2022-12-31 |
| NCT01720524 |
A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn |
https://ClinicalTrials.gov/show/NCT01720524 |
Active, not recruiting |
Pfizer |
2018-10-17 |
| NCT01682356 |
Dietary Nitrates for Heart Failure (HF) |
https://ClinicalTrials.gov/show/NCT01682356 |
Enrolling by invitation |
Washington University School of Medicine |
2019-12-31 |
| NCT01670136 |
Pharmacokinetics of Sildenafil in Premature Infants |
https://ClinicalTrials.gov/show/NCT01670136 |
Completed |
University of North Carolina, Chapel Hill |
2016-07-31 |
| NCT03349775 |
Cardiometabolic Disease and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03349775 |
Recruiting |
Massachusetts General Hospital |
2022-09-01 |
| NCT01642407 |
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT01642407 |
Completed |
Pfizer |
2016-05-20 |
| NCT01621971 |
Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients |
https://ClinicalTrials.gov/show/NCT01621971 |
Completed |
Konkuk University Medical Center |
2004-01-31 |
| NCT01615484 |
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability |
https://ClinicalTrials.gov/show/NCT01615484 |
Completed |
University of North Carolina, Chapel Hill |
2016-03-31 |
| NCT01607515 |
Non Invasive Measurement of Cardiac Index by Impedance Cardiography |
https://ClinicalTrials.gov/show/NCT01607515 |
Completed |
Medical University of Graz |
2015-06-30 |
| NCT01607489 |
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography |
https://ClinicalTrials.gov/show/NCT01607489 |
Completed |
Medical University of Graz |
2017-03-31 |
| NCT01598441 |
Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD) |
https://ClinicalTrials.gov/show/NCT01598441 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2016-11-30 |
| NCT01586156 |
PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol) |
https://ClinicalTrials.gov/show/NCT01586156 |
Completed |
The Cleveland Clinic |
2016-07-31 |
| NCT01566565 |
The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01566565 |
Completed |
Norwegian Armed Forces Medical Service |
2012-05-31 |
| NCT01539889 |
Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation |
https://ClinicalTrials.gov/show/NCT01539889 |
Completed |
Montreal Heart Institute |
2012-06-30 |
| NCT01530464 |
The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01530464 |
Completed |
Duke University |
2012-04-30 |
| NCT01529502 |
Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting |
https://ClinicalTrials.gov/show/NCT01529502 |
Completed |
Massachusetts General Hospital |
2013-12-31 |
| NCT02024386 |
Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude |
https://ClinicalTrials.gov/show/NCT02024386 |
Completed |
Duke University |
2015-12-31 |
| NCT01481350 |
Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery |
https://ClinicalTrials.gov/show/NCT01481350 |
Completed |
University of Turin, Italy |
2013-06-30 |
| NCT01469169 |
Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study |
https://ClinicalTrials.gov/show/NCT01469169 |
Completed |
Bayer |
2014-12-26 |
| NCT01463514 |
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01463514 |
Completed |
University of Zurich |
2013-06-30 |
| NCT01462565 |
Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT01462565 |
Completed |
GlaxoSmithKline |
2012-05-16 |
| NCT01457781 |
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT01457781 |
Completed |
Bellerophon |
2014-10-31 |
| NCT01446848 |
Oral Iron Supplementation in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01446848 |
Completed |
The Cleveland Clinic |
2014-08-31 |
| NCT01431313 |
Inhaled Nitrite in Subjects With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01431313 |
Completed |
University of Pittsburgh |
2017-10-31 |
| NCT01427192 |
Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01427192 |
Completed |
University of Zurich |
2012-12-31 |
| NCT01416636 |
Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) |
https://ClinicalTrials.gov/show/NCT01416636 |
Active, not recruiting |
SciPharm SÃ RL |
2016-11-30 |
| NCT01409122 |
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01409122 |
Completed |
Aires Pharmaceuticals, Inc. |
2012-01-31 |
| NCT01398345 |
Exercise and Respiratory Training as Supportive Treatments for Patients With Chronic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01398345 |
Completed |
Heidelberg University |
2006-12-31 |
| NCT01394367 |
Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01394367 |
Completed |
Heidelberg University |
2015-05-31 |
| NCT01393795 |
Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients |
https://ClinicalTrials.gov/show/NCT01393795 |
Completed |
Imperial College London |
2012-07-31 |
| NCT01364181 |
The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients |
https://ClinicalTrials.gov/show/NCT01364181 |
Completed |
Seoul National University Hospital |
2011-03-31 |
| NCT01352065 |
Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration |
https://ClinicalTrials.gov/show/NCT01352065 |
Completed |
Center for Health, Exercise and Sport Sciences, Serbia |
2012-12-31 |
| NCT01342952 |
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 |
https://ClinicalTrials.gov/show/NCT01342952 |
Active, not recruiting |
GlaxoSmithKline |
2022-06-13 |
| NCT01330108 |
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01330108 |
Completed |
University of Alabama at Birmingham |
2012-06-30 |
| NCT01324999 |
Tadalafil for Sarcoidosis Associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01324999 |
Completed |
University of North Carolina, Chapel Hill |
2013-07-31 |
| NCT01320878 |
Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease |
https://ClinicalTrials.gov/show/NCT01320878 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2009-07-31 |
| NCT04391478 |
Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT04391478 |
Completed |
Ain Shams University |
2015-04-30 |
| NCT04373902 |
Physiological-based Cord Clamping in Congenital Diaphragmatic Hernia |
https://ClinicalTrials.gov/show/NCT04373902 |
Recruiting |
Erasmus Medical Center |
2023-06-01 |
| NCT04370873 |
MK-5475 in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006) |
https://ClinicalTrials.gov/show/NCT04370873 |
Recruiting |
Merck Sharp & Dohme Corp. |
2021-05-07 |
| NCT04328636 |
Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn |
https://ClinicalTrials.gov/show/NCT04328636 |
Completed |
Sohag University |
2019-10-31 |
| NCT04326777 |
Clinical Study of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT04326777 |
Recruiting |
Beijing Chao Yang Hospital |
2023-04-30 |
| NCT04262037 |
A Comparative Study of Three Modes of Ventilation During CPB in Pediatrics With Pulmonary Hypertension Undergoing Congenital Heart Surgeries |
https://ClinicalTrials.gov/show/NCT04262037 |
Recruiting |
Cairo University |
2020-07-31 |
| NCT04224025 |
Training Single Arm |
https://ClinicalTrials.gov/show/NCT04224025 |
Recruiting |
Heidelberg University |
2025-12-31 |
| NCT04224012 |
Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT04224012 |
Recruiting |
Heidelberg University |
2021-08-31 |
| NCT04197388 |
Inspiratory Muscle Training in Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT04197388 |
Recruiting |
Golden Jubilee National Hospital |
2021-04-01 |
| NCT04152187 |
Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT04152187 |
Recruiting |
Dokuz Eylul University |
2021-05-31 |
| NCT04095286 |
Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants |
https://ClinicalTrials.gov/show/NCT04095286 |
Completed |
GlaxoSmithKline |
2019-12-17 |
| NCT04088279 |
Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH) |
https://ClinicalTrials.gov/show/NCT04088279 |
Recruiting |
Royal Brompton & Harefield NHS Foundation Trust |
2020-12-31 |
| NCT04081012 |
N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension. |
https://ClinicalTrials.gov/show/NCT04081012 |
Recruiting |
Instituto Nacional de Cardiologia Ignacio Chavez |
2023-05-21 |
| NCT04076241 |
Effects of Complementary Therapy on Cardiopulmonary Parameters in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT04076241 |
Enrolling by invitation |
Istanbul University-Cerrahpasa |
2020-09-30 |
| NCT04055415 |
Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT04055415 |
Recruiting |
Liaocheng People’s Hospital |
2020-08-01 |
| NCT04053361 |
Catheter Ablation of Atrial Fibrillation in Patients With Pulmonary Hypertension Hypertension: a Randomised Study |
https://ClinicalTrials.gov/show/NCT04053361 |
Recruiting |
General University Hospital, Prague |
2020-12-31 |
| NCT04031508 |
Effect of a Parenteral Emulsion With Omega3 on PPHN |
https://ClinicalTrials.gov/show/NCT04031508 |
Active, not recruiting |
Coordinación de Investigación en Salud, Mexico |
2022-07-31 |
| NCT04008550 |
Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI) |
https://ClinicalTrials.gov/show/NCT04008550 |
Recruiting |
University Hospital, Rouen |
2021-03-05 |
| NCT03992755 |
Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil |
https://ClinicalTrials.gov/show/NCT03992755 |
Active, not recruiting |
Liquidia Technologies, Inc. |
2021-12-31 |
| NCT03955016 |
Rehabilitation for Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03955016 |
Recruiting |
KU Leuven |
2020-11-01 |
| NCT03928002 |
4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease |
https://ClinicalTrials.gov/show/NCT03928002 |
Recruiting |
Centre Chirurgical Marie Lannelongue |
2020-04-01 |
| NCT03901287 |
Quantitative Dual Energy Computed Tomography in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03901287 |
Recruiting |
University Hospital, Bordeaux |
2020-12-15 |
| NCT03854071 |
Development of Novel Physiological CMR Methods in Health and Disease |
https://ClinicalTrials.gov/show/NCT03854071 |
Recruiting |
Sheffield Teaching Hospitals NHS Foundation Trust |
2022-06-04 |
| NCT03835676 |
Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT03835676 |
Recruiting |
Magdi Yacoub Heart Foundation |
2022-06-01 |
| NCT03814317 |
Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03814317 |
Recruiting |
University of Florida |
2020-09-30 |
| NCT03810482 |
Pedometers and Walking Tests for Pulmonary Hypertension Patients |
https://ClinicalTrials.gov/show/NCT03810482 |
Recruiting |
University Hospital, Montpellier |
2021-06-21 |
| NCT03809650 |
A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH). |
https://ClinicalTrials.gov/show/NCT03809650 |
Recruiting |
Actelion |
2022-12-31 |
| NCT03809156 |
Upfront Combination Pulmonary Arterial Hypertension Therapy |
https://ClinicalTrials.gov/show/NCT03809156 |
Recruiting |
University of Calgary |
2020-12-31 |
| NCT03795740 |
Pulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension—-PEACT |
https://ClinicalTrials.gov/show/NCT03795740 |
Recruiting |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2020-05-31 |
| NCT03794583 |
Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) |
https://ClinicalTrials.gov/show/NCT03794583 |
Enrolling by invitation |
United Therapeutics |
2020-12-31 |
| NCT03780803 |
Effect of Home Rehabilitation on State of Patients With PAH, HFREF and IHD |
https://ClinicalTrials.gov/show/NCT03780803 |
Recruiting |
Medical University of Bialystok |
2020-12-31 |
| NCT03763045 |
Sildenafil in Hemodialysis Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03763045 |
Active, not recruiting |
Ain Shams University |
2019-02-16 |
| NCT03762577 |
Effects of Ground-based Walking Training in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03762577 |
Completed |
Istanbul University |
2020-03-04 |
| NCT03757481 |
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE |
https://ClinicalTrials.gov/show/NCT03757481 |
Recruiting |
University Hospital, Montpellier |
2020-10-17 |
| NCT03754660 |
This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) |
https://ClinicalTrials.gov/show/NCT03754660 |
Recruiting |
Bayer |
2021-06-22 |
| NCT03729544 |
Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism |
https://ClinicalTrials.gov/show/NCT03729544 |
Recruiting |
Brigham and Women’s Hospital |
2021-01-30 |
| NCT03727451 |
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis |
https://ClinicalTrials.gov/show/NCT03727451 |
Recruiting |
Bellerophon |
2020-06-30 |
| NCT03719027 |
Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH) |
https://ClinicalTrials.gov/show/NCT03719027 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-12-31 |
| NCT03689244 |
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or International Treatment |
https://ClinicalTrials.gov/show/NCT03689244 |
Recruiting |
Actelion |
2021-03-26 |
| NCT03673774 |
Impedancemetry in Patients Monitored for Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03673774 |
Recruiting |
University Hospital, Toulouse |
2019-08-31 |
| NCT03649932 |
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing |
https://ClinicalTrials.gov/show/NCT03649932 |
Recruiting |
The University of Texas Medical Branch, Galveston |
2019-09-10 |
| NCT03648385 |
Effects of DHEA in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03648385 |
Recruiting |
Rhode Island Hospital |
2023-04-30 |
| NCT03637218 |
Acute Exposure of High Altitude on Cardiac Output |
https://ClinicalTrials.gov/show/NCT03637218 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03637192 |
Acute Exposure of High Altitude on Cognitive Function |
https://ClinicalTrials.gov/show/NCT03637192 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03637179 |
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise |
https://ClinicalTrials.gov/show/NCT03637179 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03637166 |
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) |
https://ClinicalTrials.gov/show/NCT03637166 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03637153 |
Acute Exposure to High Altitude on Exercise Capacity |
https://ClinicalTrials.gov/show/NCT03637153 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03637140 |
Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise |
https://ClinicalTrials.gov/show/NCT03637140 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03637127 |
Acute Exposure of Simulated Hypoxia on Cognitive Function |
https://ClinicalTrials.gov/show/NCT03637127 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03637114 |
Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS) |
https://ClinicalTrials.gov/show/NCT03637114 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03637088 |
Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) |
https://ClinicalTrials.gov/show/NCT03637088 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03630211 |
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03630211 |
Recruiting |
University of Pittsburgh |
2023-08-01 |
| NCT03624010 |
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients |
https://ClinicalTrials.gov/show/NCT03624010 |
Active, not recruiting |
Tenax Therapeutics, Inc. |
2022-04-30 |
| NCT03611270 |
TReatment of Pulmonary Hypertension Group II Study |
https://ClinicalTrials.gov/show/NCT03611270 |
Recruiting |
SoniVie Ltd. |
2020-07-31 |
| NCT03600415 |
Acute Exposure to High Altitude on Blood and Tissue Oxygenation (ABGA, NIRS) |
https://ClinicalTrials.gov/show/NCT03600415 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03593096 |
Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise |
https://ClinicalTrials.gov/show/NCT03593096 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03593083 |
Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure. |
https://ClinicalTrials.gov/show/NCT03593083 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03593005 |
Acute Exposure to High Altitude on Symptoms |
https://ClinicalTrials.gov/show/NCT03593005 |
Completed |
University of Zurich |
2019-01-01 |
| NCT03592979 |
Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During Exercise |
https://ClinicalTrials.gov/show/NCT03592979 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03592927 |
Acute Exposure to Simulated Hypoxia on Exercise Capacity |
https://ClinicalTrials.gov/show/NCT03592927 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03581877 |
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE |
https://ClinicalTrials.gov/show/NCT03581877 |
Recruiting |
Northwell Health |
2021-12-31 |
| NCT03581851 |
Acute Exposure of Simulated Hypoxia on ECG and Non-invasive Blood Pressure |
https://ClinicalTrials.gov/show/NCT03581851 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03576885 |
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia |
https://ClinicalTrials.gov/show/NCT03576885 |
Recruiting |
AdventHealth |
2021-08-31 |
| NCT03574675 |
Acute Exposure of Simulated Hypoxia on Cardiac Output |
https://ClinicalTrials.gov/show/NCT03574675 |
Completed |
University of Zurich |
2019-04-01 |
| NCT03554291 |
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03554291 |
Recruiting |
University of Washington |
2022-07-31 |
| NCT03550729 |
Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03550729 |
Recruiting |
Hospital Clinic of Barcelona |
2019-08-31 |
| NCT03542812 |
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia |
https://ClinicalTrials.gov/show/NCT03542812 |
Recruiting |
University of Utah |
2021-06-30 |
| NCT03541603 |
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF |
https://ClinicalTrials.gov/show/NCT03541603 |
Completed |
Tenax Therapeutics, Inc. |
2020-04-07 |
| NCT03528902 |
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT03528902 |
Recruiting |
Vanderbilt University Medical Center |
2022-06-30 |
| NCT03523910 |
Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03523910 |
Completed |
University of Wisconsin, Madison |
2017-02-13 |
| NCT03496623 |
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With PH Due to COPD |
https://ClinicalTrials.gov/show/NCT03496623 |
Recruiting |
United Therapeutics |
2020-09-30 |
| NCT03438123 |
Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera |
https://ClinicalTrials.gov/show/NCT03438123 |
Completed |
Spectrum Dynamics |
2019-10-15 |
| NCT03431649 |
Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children |
https://ClinicalTrials.gov/show/NCT03431649 |
Completed |
Dr. Soetomo General Hospital |
2017-07-30 |
| NCT01260454 |
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain |
https://ClinicalTrials.gov/show/NCT01260454 |
Completed |
University of Rochester |
2011-12-31 |
| NCT01224210 |
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial |
https://ClinicalTrials.gov/show/NCT01224210 |
Active, not recruiting |
Tufts Medical Center |
2016-10-31 |
| NCT01212523 |
Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance |
https://ClinicalTrials.gov/show/NCT01212523 |
Completed |
University Hospitals Bristol NHS Foundation Trust |
2011-12-31 |
| NCT01197469 |
Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension? |
https://ClinicalTrials.gov/show/NCT01197469 |
Completed |
University of Dundee |
2012-09-30 |
| NCT01185730 |
Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking Anorectics |
https://ClinicalTrials.gov/show/NCT01185730 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-01-31 |
| NCT01179334 |
Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters. |
https://ClinicalTrials.gov/show/NCT01179334 |
Completed |
Bayer |
2012-06-30 |
| NCT01178073 |
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT01178073 |
Completed |
GlaxoSmithKline |
2014-07-31 |
| NCT01156636 |
Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure |
https://ClinicalTrials.gov/show/NCT01156636 |
Completed |
University of Milan |
2009-09-30 |
| NCT01121458 |
Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed |
https://ClinicalTrials.gov/show/NCT01121458 |
Completed |
North Texas Veterans Healthcare System |
2013-04-30 |
| NCT01104870 |
A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01104870 |
Completed |
United Therapeutics |
2013-01-31 |
| NCT01100008 |
Cardiac Magnetic Resonance Imaging and Pulmonary Perfusion |
https://ClinicalTrials.gov/show/NCT01100008 |
Completed |
University Hospital, Toulouse |
2013-09-30 |
| NCT01083524 |
Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT01083524 |
Completed |
University of Alberta |
2013-09-30 |
| NCT01065454 |
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction |
https://ClinicalTrials.gov/show/NCT01065454 |
Active, not recruiting |
Bayer |
2012-06-06 |
| NCT01055405 |
Study of Sildenafil Effects in Combination With Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01055405 |
Completed |
Hospital Clinic of Barcelona |
2011-03-31 |
| NCT01051960 |
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan |
https://ClinicalTrials.gov/show/NCT01051960 |
Completed |
University of California, Los Angeles |
2010-06-30 |
| NCT01048905 |
Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT01048905 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2014-03-31 |
| NCT01042158 |
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT01042158 |
Completed |
Johns Hopkins University |
2014-11-30 |
| NCT01038284 |
Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT01038284 |
Completed |
University Hospital, Grenoble |
2014-02-28 |
| NCT00984932 |
Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00984932 |
Completed |
University of Alexandria |
2009-07-31 |
| NCT00963027 |
Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil |
https://ClinicalTrials.gov/show/NCT00963027 |
Completed |
United Therapeutics |
2009-10-31 |
| NCT00963001 |
Effect of Food on the Pharmacokinetics of Oral Treprostinil |
https://ClinicalTrials.gov/show/NCT00963001 |
Completed |
United Therapeutics |
2009-11-30 |
| NCT00952302 |
Study of the Effects of Iron Levels on the Lungs at High Altitude |
https://ClinicalTrials.gov/show/NCT00952302 |
Completed |
University of Oxford |
2008-11-30 |
| NCT00910429 |
BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00910429 |
Completed |
Bayer |
2019-08-19 |
| NCT00909337 |
Early Therapy of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00909337 |
Completed |
Medical University of Graz |
2010-06-30 |
| NCT00887978 |
Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00887978 |
Completed |
United Therapeutics |
2011-07-31 |
| NCT00878878 |
Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR). |
https://ClinicalTrials.gov/show/NCT00878878 |
Completed |
GE Healthcare |
2010-07-31 |
| NCT00872170 |
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00872170 |
Completed |
HealthCore-NERI |
2010-06-30 |
| NCT00863681 |
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00863681 |
Completed |
Bayer |
2019-08-19 |
| NCT00862043 |
Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease |
https://ClinicalTrials.gov/show/NCT00862043 |
Completed |
Hospital General Universitario Gregorio Marañon |
2016-07-31 |
| NCT00855465 |
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. |
https://ClinicalTrials.gov/show/NCT00855465 |
Completed |
Bayer |
2012-06-30 |
| NCT02021292 |
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02021292 |
Completed |
Actelion |
2016-09-28 |
| NCT00851929 |
Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00851929 |
Completed |
Medical University of South Carolina |
2011-04-30 |
| NCT03388476 |
Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT03388476 |
Enrolling by invitation |
University of Giessen |
2021-01-01 |
| NCT03229499 |
Pulmonary Hypertension and Anastrozole Trial |
https://ClinicalTrials.gov/show/NCT03229499 |
Active, not recruiting |
University of Pennsylvania |
2021-09-30 |
| NCT03199131 |
The Right Ventricle in Chronic Pressure Overload: Identifying Novel Molecular Targets for Functional Imaging |
https://ClinicalTrials.gov/show/NCT03199131 |
Completed |
Centre Chirurgical Marie Lannelongue |
2017-11-20 |
| NCT00810693 |
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT00810693 |
Completed |
Bayer |
2012-05-31 |
| NCT00808912 |
Does Sildenafil Increase Exercise Performance in Air Pollution? |
https://ClinicalTrials.gov/show/NCT00808912 |
Completed |
Marywood University |
2010-02-28 |
| NCT02951429 |
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02951429 |
Active, not recruiting |
Hoffmann-La Roche |
2019-09-26 |
| NCT02760121 |
AZ, MZ, and the Pulmonary System Response to Hypoxia |
https://ClinicalTrials.gov/show/NCT02760121 |
Completed |
University of British Columbia |
2016-08-31 |
| NCT03683186 |
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension |
https://ClinicalTrials.gov/show/NCT03683186 |
Enrolling by invitation |
United Therapeutics |
2024-09-30 |
| NCT02345616 |
Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibility |
https://ClinicalTrials.gov/show/NCT02345616 |
Recruiting |
University Hospital, Clermont-Ferrand |
2019-12-31 |
| NCT02267655 |
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF |
https://ClinicalTrials.gov/show/NCT02267655 |
Completed |
Bellerophon |
2017-06-30 |
| NCT01829672 |
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography |
https://ClinicalTrials.gov/show/NCT01829672 |
Completed |
Medical University of Graz |
2017-03-31 |
| NCT03726398 |
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH |
https://ClinicalTrials.gov/show/NCT03726398 |
Recruiting |
University of Arizona |
2020-01-31 |
| NCT00777920 |
Study of Ambrisentan in Subjects With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00777920 |
Completed |
Gilead Sciences |
2019-09-11 |
| NCT00759408 |
The Role of Endothelin in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00759408 |
Completed |
Brigham and Women’s Hospital |
2010-10-31 |
| NCT00747045 |
Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients |
https://ClinicalTrials.gov/show/NCT00747045 |
Completed |
University of California, San Diego |
2011-03-31 |
| NCT00739375 |
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension. |
https://ClinicalTrials.gov/show/NCT00739375 |
Completed |
Shaare Zedek Medical Center |
2012-04-30 |
| NCT00718952 |
The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00718952 |
Completed |
Tongji University |
2009-12-31 |
| NCT00694850 |
Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH) |
https://ClinicalTrials.gov/show/NCT00694850 |
Active, not recruiting |
Bayer |
2021-10-01 |
| NCT00680654 |
Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID |
https://ClinicalTrials.gov/show/NCT00680654 |
Completed |
Bayer |
2009-08-31 |
| NCT00678821 |
Aerobic Exercise in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00678821 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-09-23 |
| NCT00800592 |
Sildenafil IV Bolus Study |
https://ClinicalTrials.gov/show/NCT00800592 |
Completed |
Pfizer |
2008-12-31 |
| NCT00657722 |
Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension |
https://ClinicalTrials.gov/show/NCT00657722 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-07-31 |
| NCT00644605 |
A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00644605 |
Completed |
Pfizer |
NA |
| NCT00640315 |
Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. |
https://ClinicalTrials.gov/show/NCT00640315 |
Completed |
Bayer |
2009-09-30 |
| NCT00615823 |
Atorvastatin in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00615823 |
Completed |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2010-03-31 |
| NCT00595049 |
Pulmonary Artery Remodelling With Bosentan |
https://ClinicalTrials.gov/show/NCT00595049 |
Completed |
Actelion |
2008-12-31 |
| NCT00581607 |
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00581607 |
Completed |
University of Cincinnati |
2012-10-31 |
| NCT00561223 |
Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD) |
https://ClinicalTrials.gov/show/NCT00561223 |
Completed |
University of Oklahoma |
2008-04-30 |
| NCT00559442 |
Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction |
https://ClinicalTrials.gov/show/NCT00559442 |
Completed |
Heidelberg University |
2010-12-31 |
| NCT00554619 |
A Study to Evaluate GSK1325760A - a Long-Term Extension Study |
https://ClinicalTrials.gov/show/NCT00554619 |
Completed |
GlaxoSmithKline |
2011-01-31 |
| NCT00549302 |
Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs |
https://ClinicalTrials.gov/show/NCT00549302 |
Completed |
Eli Lilly and Company |
2012-02-29 |
| NCT00540436 |
Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00540436 |
Completed |
GlaxoSmithKline |
2009-01-31 |
| NCT00519870 |
Losartan Therapy in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00519870 |
Completed |
Baskent University |
NA |
| NCT00517933 |
Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00517933 |
Completed |
Duke University |
2009-05-31 |
| NCT00491803 |
Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD) |
https://ClinicalTrials.gov/show/NCT00491803 |
Completed |
Hospital Clinic of Barcelona |
2008-11-30 |
| NCT00491309 |
Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00491309 |
Recruiting |
Heidelberg University |
2022-12-31 |
| NCT00477724 |
Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy |
https://ClinicalTrials.gov/show/NCT00477724 |
Recruiting |
Heidelberg University |
2022-12-31 |
| NCT00469027 |
Pulmonary Hypertension: Assessment of Cell Therapy |
https://ClinicalTrials.gov/show/NCT00469027 |
Completed |
Northern Therapeutics |
2012-07-31 |
| NCT00454558 |
An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00454558 |
Completed |
Bayer |
2014-07-31 |
| NCT00454207 |
Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00454207 |
Completed |
Pfizer |
2009-02-28 |
| NCT00432978 |
Effect of Bosentan on Exercise Capacity at High Altitude |
https://ClinicalTrials.gov/show/NCT00432978 |
Completed |
VA Loma Linda Health Care System |
NA |
| NCT00424021 |
Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00424021 |
Completed |
Gilead Sciences |
2009-12-31 |
| NCT00423592 |
Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00423592 |
Completed |
Gilead Sciences |
2006-01-31 |
| NCT00414687 |
Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00414687 |
Completed |
Bayer |
NA |
| NCT00403650 |
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00403650 |
Completed |
University of Cincinnati |
2008-07-31 |
| NCT00820352 |
Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00820352 |
Completed |
University Teaching Hospital Hall in Tirol |
2014-06-30 |
| NCT00380068 |
Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00380068 |
Completed |
Gilead Sciences |
2008-07-31 |
| NCT00927654 |
Iloprost in High Risk Cardiac Surgical Patients |
https://ClinicalTrials.gov/show/NCT00927654 |
Completed |
Ludwig-Maximilians - University of Munich |
2012-03-31 |
| NCT00373360 |
Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin |
https://ClinicalTrials.gov/show/NCT00373360 |
Completed |
United Therapeutics |
2008-01-31 |
| NCT00359736 |
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00359736 |
Completed |
VA Office of Research and Development |
2008-10-31 |
| NCT00352482 |
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00352482 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00352430 |
Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00352430 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-03-10 |
| NCT00345774 |
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease |
https://ClinicalTrials.gov/show/NCT00345774 |
Completed |
Epix Pharmaceuticals, Inc. |
NA |
| NCT00335244 |
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery |
https://ClinicalTrials.gov/show/NCT00335244 |
Completed |
Asklepion Pharmaceuticals, LLC |
2009-12-31 |
| NCT00334490 |
Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery? |
https://ClinicalTrials.gov/show/NCT00334490 |
Completed |
St. Michael’s Hospital, Toronto |
2009-04-30 |
| NCT00325442 |
FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT00325442 |
Completed |
United Therapeutics |
2008-09-30 |
| NCT00325403 |
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT00325403 |
Completed |
United Therapeutics |
2011-04-30 |
| NCT00319111 |
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) |
https://ClinicalTrials.gov/show/NCT00319111 |
Completed |
Actelion |
2009-02-28 |
| NCT00314548 |
Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00314548 |
Completed |
Aga Khan University |
2009-07-31 |
| NCT00313222 |
Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00313222 |
Completed |
Actelion |
2007-02-28 |
| NCT00274430 |
Prevention of High Altitude Pulmonary Edema |
https://ClinicalTrials.gov/show/NCT00274430 |
Completed |
University of Zurich |
NA |
| NCT00270478 |
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia |
https://ClinicalTrials.gov/show/NCT00270478 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-08-31 |
| NCT00240656 |
Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00240656 |
Completed |
Hebei Medical University |
NA |
| NCT00235521 |
Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery |
https://ClinicalTrials.gov/show/NCT00235521 |
Completed |
Heidelberg University |
2008-10-31 |
| NCT00205426 |
Natrecor for Pulmonary Hypertension in Lung Transplants |
https://ClinicalTrials.gov/show/NCT00205426 |
Completed |
University of Wisconsin, Madison |
2006-05-31 |
| NCT00190333 |
Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00190333 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-12-31 |
| NCT00185315 |
Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00185315 |
Completed |
Bayer |
NA |
| NCT00180713 |
Simvastatin as a Treatment for Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00180713 |
Completed |
Imperial College London |
2008-10-31 |
| NCT00159887 |
Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00159887 |
Completed |
Pfizer |
NA |
| NCT00159861 |
The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH |
https://ClinicalTrials.gov/show/NCT00159861 |
Completed |
Pfizer |
NA |
| NCT00147199 |
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT00147199 |
Completed |
United Therapeutics |
2007-10-31 |
| NCT00139217 |
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn |
https://ClinicalTrials.gov/show/NCT00139217 |
Completed |
Emory University |
2007-09-30 |
| NCT00125918 |
PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00125918 |
Completed |
Eli Lilly and Company |
2007-08-31 |
| NCT00109681 |
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00109681 |
Completed |
Actelion |
2006-10-31 |
| NCT00105209 |
A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00105209 |
Completed |
Kawut, Steven, MD |
NA |
| NCT00091715 |
Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II |
https://ClinicalTrials.gov/show/NCT00091715 |
Completed |
Actelion |
2006-11-30 |
| NCT00091598 |
ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT00091598 |
Completed |
Gilead Sciences |
2006-02-28 |
| NCT00819377 |
Milrinone Inhaled in Cardiac Surgery |
https://ClinicalTrials.gov/show/NCT00819377 |
Completed |
Montreal Heart Institute |
2012-01-31 |
| NCT00086463 |
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) |
https://ClinicalTrials.gov/show/NCT00086463 |
Completed |
Actelion |
2006-01-31 |
| NCT00082186 |
The Effect of Tracleer® on Male Fertility |
https://ClinicalTrials.gov/show/NCT00082186 |
Completed |
Actelion |
2007-02-28 |
| NCT00080457 |
Safety and Efficacy Study of Sitaxentan Sodium (Thelinâ„¢) in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00080457 |
Completed |
Encysive Pharmaceuticals |
NA |
| NCT00058929 |
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00058929 |
Completed |
United Therapeutics |
2005-08-31 |
| NCT00046319 |
Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00046319 |
Completed |
Gilead Sciences |
NA |
| NCT00023296 |
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00023296 |
Completed |
National Institutes of Health Clinical Center (CC) |
2006-11-02 |
| NCT00004805 |
Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death |
https://ClinicalTrials.gov/show/NCT00004805 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004754 |
Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00004754 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004497 |
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00004497 |
Completed |
FDA Office of Orphan Products Development |
NA |